CONMED Corporation to Announce First Quarter 2023 Financial Results on April 26, 2023

Rhea-AI Summary

CONMED Corporation (NYSE: CNMD) will announce its Q1 2023 financial results on April 26, 2023, after market close. Management will host a conference call at 4:30 p.m. ET to discuss these results. Investors can participate via telephone or listen to a webcast on CONMED's website. The company produces surgical devices for various specialties, including orthopedics and general surgery. Forward-looking statements in the release highlight risks from the ongoing COVID-19 pandemic, which may affect operational performance.

Positive

• Scheduled announcement of Q1 2023 financial results indicates ongoing transparency.
• Management is engaging with investors through a conference call and webcast.

Negative

• Risks related to the COVID-19 pandemic may impact business performance.
• Potential deferral of surgeries and reduced operating volumes in healthcare facilities.

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2023 after the market close on Wednesday, April 26, 2023. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode.

This conference call will also be webcast and can be accessed from the “Investors” section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release and the associated conference call may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability; any assumptions underlying any of the foregoing as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2022, listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-K and other risks and uncertainties which may be detailed from time to time in reports filed by CONMED with the SEC. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230404006035/en/

CONMED Corporation

Todd W. Garner

Chief Financial Officer

727-214-2975

ToddGarner@conmed.com

Source: CONMED Corporation

FAQ

When will CONMED Corporation report its Q1 2023 financial results?

CONMED Corporation will report its Q1 2023 financial results on April 26, 2023, after market close.

What time is the CONMED conference call for financial results?

The CONMED conference call to discuss financial results is scheduled for 4:30 p.m. ET on April 26, 2023.

How can I listen to the CONMED Q1 2023 earnings call?

You can listen to the CONMED Q1 2023 earnings call via telephone or by accessing the webcast from the investors section of their website.

What risks does CONMED mention in their press release?

CONMED mentions risks related to the COVID-19 pandemic, including potential surgery deferrals and disruptions to supply chains.

Where can I find more information about CONMED's products?

More information about CONMED's medical technology products can be found on their website at www.conmed.com.